The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Ogorodnikov D.V.

The Centre of Reproduction and Genetics «Nova Clinic», Moscow, Russia, 119415

Dobrokhotova Iu.É.

Kafedra akusherstva i ginekologii Moskovskogo fakul'teta Rossiĭskogo gosudarstvennogo meditsinskogo universiteta

Progesterone profiles in follicular phase of the natural and induced cycles

Authors:

Ogorodnikov D.V., Dobrokhotova Iu.É.

More about the authors

Journal: Russian Journal of Human Reproduction. 2017;23(2): 14‑21

Read: 13475 times


To cite this article:

Ogorodnikov DV, Dobrokhotova IuÉ. Progesterone profiles in follicular phase of the natural and induced cycles. Russian Journal of Human Reproduction. 2017;23(2):14‑21. (In Russ.)
https://doi.org/10.17116/repro201723214-21

References:

  1. Venetis C, Kolibianakis E, Bosdou J, Lainas G, Sfontouris I, Tarlatzis B, Lainas T. Estimating the net effect of progesterone elevation on the day of hCG on live birth rates after IVF: a cohort analysis of 3296 IVF cycles. Human Reproduction. 2015;30(3):684-691. doi:10.1093/humrep/deu362
  2. Bosch E. High responders and patients with a good prognosis are not immune to the negative impact on live birth rate of elevated P on the day of triggering. Fertility and Sterility. 2015;103(6):1423. doi:10.1016/j.fertnstert.2015.03.031
  3. Bosch E, Labarta E, Crespo J, Simon C, Remohi J, Jenkins J, Pellicer A. Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles. Human Reproduction. 2010;25(8):2092-2100. doi:10.1093/humrep/deq125
  4. Ogorodnikov D.V., Dobrokhotova Yu.E. Vysokii uroven' progesterona v protsesse kontroliruemoi ovarial'noi stimulyatsii protokola EKO. Chto stradaet — yaitsekletka ili endometrii? Problemy reproduktsii. 2016;22(5):51-55. doi:10.17116/repro201622551-55
  5. Lin Y, Lan K, Huang F, Lin P, Chiang H, Kung F. Reproducibility and clinical significance of pre-ovulatory serum progesterone level and progesterone/estradiol ratio on the day of human chorionic gonadotropin administration in infertile women undergoing repeated in vitro fertilization cycles. Reprod Biol Endocrinol. 2015;13(1). doi:10.1186/s12958-015-0037-9
  6. Lai T, Lee F, Lin T, Horng S, Chen S, Chen Y, Wang P. An increased serum progesterone-to-estradiol ratio on the day of human chorionic gonadotropin administration does not have a negative impact on clinical pregnancy rate in women with normal ovarian reserve treated with a long gonadotropin releasing hormone agonist protocol. Fertility and Sterility. 2009;92(2):508-514. doi:10.1016/j.fertnstert.2008.06.036
  7. De Geyter C. Progesterone serum levels during the follicular phase of the menstrual cycle originate from the crosstalk between the ovaries and the adrenal cortex. Human Reproduction. 2002;17(4):933-939. doi:10.1093/humrep/17.4.933
  8. Al-Azemi M, Kyrou D, Kolibianakis E, Humaidan P, Van Vaerenbergh I, Devroey P, Fatemi H. Elevated progesterone during ovarian stimulation for IVF. Reproductive BioMedicine Online. 2012;24(4):381-388. doi:10.1016/j.rbmo.2012.01.010
  9. Fanchin R, Hourvitz A, Olivennes F, Taieb J, Hazout A, Frydman R. Premature progesterone elevation spares blastulation but not pregnancy rates in in vitro fertilization with coculture. Fertility and Sterility. 1997;68(4):648-652. doi:10.1016/s0015-0282(97)80464-5
  10. Keck C, Neulen J, Breig-Lauel S, Breckwoldt M. Elevated serum progesterone concentrations during the early follicular phase of the menstrual cycle: Clinical significance and therapeutic implications. Gynecological Endocrinology. 1999;13(3):161-165. doi:10.3109/09513599909167550
  11. Chabbert-Buffeta N. Neuroendocrine effects of progesterone. Steroids. 2000;65(10-11):613-620. doi:10.1016/s0039-128x(00)00187-2
  12. Micevych P, Sinchak K. Synthesis and Function of Hypothalamic Neuroprogesterone in Reproduction. Endocrinology. 2008;149(6):2739-2742. doi:10.1210/en.2008-0011
  13. Sonigo C, Dray G, Roche C, Cédrin-Durnerin I, Hugues J. Impact of high serum progesterone during the late follicular phase on IVF outcome. Reproductive BioMedicine Online. 2014;29(2):177-186. doi:10.1016/j.rbmo.2014.03.027
  14. Lindeberg M, Carlstrom K, Ritvos O, Hovatta O. Gonadotrophin stimulation of non-luteinized granulosa cells increases steroid production and the expression of enzymes involved in estrogen and progesterone synthesis. Human Reproduction. 2006;22(2):401-406. doi:10.1093/humrep/del408
  15. Tang Y, Gong F, Lin G, Lu G. Early follicular progesterone concentrations and in vitro fertilization pregnancy outcomes. Fertility and Sterility. 2007;87(4):991-994. doi:10.1016/j.fertnstert.2006.08.087
  16. Kolibianakis E. Elevated progesterone at initiation of stimulation is associated with a lower ongoing pregnancy rate after IVF using GnRH antagonists. Human Reproduction. 2004;19(7):1525-1529. doi:10.1093/humrep/deh272
  17. Ubaldi F, Albano C, Peukert M, Riethmuller-Winzen H, Camus M, Smitz J, Steirteghem A, Devroey P. Endocrinology: Subtle progesterone rise after the administration of the gonadotrophin-releasing hormone antagonist Cetrorelix in intracytoplasmic sperm injection cycles. Human Reproduction. 1996;11(7):1405-1407. doi:10.1093/oxfordjournals.humrep.a019409
  18. Younis J, Matilsky M, Radin O, Ben-Ami M. Increased progesterone/estradiol ratio in the late follicular phase could be related to low ovarian reserve in in vitro fertilization–embryo transfer cycles with a long gonadotropin-releasing hormone agonist. Fertility and Sterility. 2001;76(2):294-299. doi:10.1016/s0015-0282(01)01918-5
  19. Roque M, Valle M, Sampaio M, Geber S, Checa M. Ratio of progesterone-to-number of follicles as a prognostic tool for in vitro fertilization cycles. Journal of Assisted Reproduction and Genetics. 2015;32(6):951-957. doi:10.1007/s10815-015-0487-1
  20. Kyrou D, Al-Azemi M, Papanikolaou E, Donoso P, Tziomalos K, Devroey P, Fatemi H. The relationship of premature progesterone rise with serum estradiol levels and number of follicles in GnRH antagonist/recombinant FSH-stimulated cycles. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2012;162(2):165-168. doi:10.1016/j.ejogrb.2012.02.025
  21. Kolibianakis E, Albano C, Camus M, Tournaye H, Van Steirteghem A, Devroey P. Prolongation of the follicular phase in in vitro fertilization results in a lower ongoing pregnancy rate in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists. Fertility and Sterility. 2004;82(1):102-107. doi:10.1016/j.fertnstert.2004.01.027
  22. Fleming R, Jenkins J. The source and implications of progesterone rise during the follicular phase of assisted reproduction cycles. Reproductive BioMedicine Online. 2010;21(4):446-449. doi:10.1016/j.rbmo.2010.05.018
  23. Andersen A, Devroey P, Arce J. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. Human Reproduction. 2006;21(12):3217-3227. doi:10.1093/humrep/del284
  24. Ji J, Liu Y, Tong X, Luo L, Ma J, Chen Z. The optimum number of oocytes in IVF treatment: an analysis of 2455 cycles in China. Human Reproduction. 2013;28(10):2728-2734. doi:10.1093/humrep/det303
  25. Hugues J. Impact of 'LH activity' supplementation on serum progesterone levels during controlled ovarian stimulation: a systematic review. Human Reproduction. 2011;27(1):232-243. doi:10.1093/humrep/der380
  26. Thuesen L, Smitz J, Loft A, Nyboe Andersen A. Endocrine effects of hCG supplementation to recombinant FSH throughout controlled ovarian stimulation for IVF: a dose-response study. Clinical Endocrinology. 2013;p.n/a-n/a. doi:10.1111/cen.12186
  27. Devroey P, Pellicer A, Nyboe Andersen A, Arce J. A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer. Fertility and Sterility. 2012;97(3):561-571. doi:10.1016/j.fertnstert.2011.12.016
  28. Hugues J, Massé-Laroche E, Reboul-Marty J, Boîko O, Meynant C, Cédrin-Durnerin I. Impact of endogenous luteinizing hormone serum levels on progesterone elevation on the day of human chorionic gonadotropin administration. Fertility and Sterility. 2011;96(3):600-604. doi:10.1016/j.fertnstert.2011.06.061
  29. Jayaprakasan K, Campbell B, Hopkisson J, Clewes J, Johnson I, Raine-Fenning N. Effect of pituitary desensitization on the early growing follicular cohort estimated using anti-Mullerian hormone. Human Reproduction. 2008;23(11):2577-2583. doi:10.1093/humrep/den282

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.